Introduction {#Sec1}
============

Over 91% of the world's population lives in areas of poor air quality with air pollutant concentrations exceeding the World Health Organization reference limits \[[@CR1]\]. The State of Global Air 2019 report published by the Health Effects Institute (HEI) indicated that air pollution (Particulate Matter 2.5 (PM~2.5~), ozone, and household air pollution) is the fifth leading risk factor for mortality worldwide and in 2017, air pollution is estimated to have contributed to close to 5 million deaths globally \[[@CR2]\].

Air pollutants can be grouped into gaseous pollutants (e.g., sulfur dioxide, nitrogen oxides, carbon monoxide, ozone, and volatile organic compounds), persistent organic pollutants (e.g., dioxins), heavy metals (e.g., cadmium, lead, mercury), and particulate matter (PM).

Among many sources, the primary source of PM is due to anthropogenic activities, arising from the combustion of fossil fuels used for transport and the generation of energy \[[@CR3]\]. Traffic is one of the most significant contributors to urban PM \[[@CR4]\], resulting in a ubiquitous air distribution. PM is a complex mixture, and the concentration, particle size, and chemical properties of PM vary widely in space and time. PM consists of primary particles, which are emitted directly to the atmosphere as a result of incomplete combustion processes or are produced by the abrasion of tires, of brakes, road surfaces, and the generation of fugitive dust. Additionally, PM contains secondary particles, which are chemically formed in the atmosphere from gaseous precursors \[[@CR5]\]. Because of their fissured structure, these particles offer an ideal surface for the attachment of other (toxic) substances. According to the US Environmental and Protection Agency (EPA), PM can be classified according to particle size (diameter) as follows, PM~0.1~ (ultrafine particles, ≤ 0.1 μm), PM~2.5~ (fine particles, ≤ 2.5 μm), PM~10~ (coarse particles, ≤ 10 μm) \[[@CR6]\].

The PM~10~ fraction consists primarily of crustal materials, sea salt, biological factors, including bacteria and fragments of pollen, and are generated by mechanical processes rather than combustion. On the other hand, PM~2.5~ and PM~0.1~ are predominantly produced by combustion processes and consist primarily of metals, hydrocarbons, and secondary particles formed by chemical reactions with gaseous compounds in the atmosphere \[[@CR7], [@CR8]\]. The majority of the particle mass is in a fraction of less than 2.5 μm, with the largest number of particles in the fraction in less than 0.1 μm. PM~0.1~ with the greater surface area can carry a large amount of adsorbed pollutants, oxygen gases, organic compounds, and transition metals \[[@CR9]\]. An example of hydrocarbons that are frequently adsorbed on the PM's surface is polycyclic aromatic hydrocarbons (PAHs) \[[@CR10]\]. PAHs are considered to cause one of the most relevant health hazards due to their ability to induce the formation of reactive oxygen species (ROS) \[[@CR11]\], as mediators of cardiovascular effects \[[@CR12]\] and increases the risks of cancer in humans \[[@CR13]\].

Long-term effects of air pollution on the pulmonary and cardiovascular system have been extensively studied, and include a strong correlation between different levels of air pollution and mortality, exacerbation of asthma, chronic bronchitis, respiratory tract infections, ischemic heart disease and stroke \[[@CR14]\]. Although most of the attention of airborne PM has focused on the impact on human respiratory and cardiovascular systems \[[@CR15], [@CR16]\], many other primary and secondary organs (e.g., skin, gut, liver, kidney) are affected upon repetitive exposure to PM \[[@CR17]\]. Indeed, because of its peculiar location, human skin acts as a biological shield against air pollutants, and prolonged and repetitive exposure to high levels of airborne PM has been shown to have profound adverse effects on cutaneous tissue \[[@CR18]--[@CR21]\].

This review highlights the current understanding of the impact of airborne PM on the skin and the underlying physiological mechanisms that are affected. Furthermore, it provides an in-depth overview of in vivo and in vitro studies of airborne PM exposure to skin and lists the biomarkers of interest and findings. The following search engines and databases, PubMed, ScienceDirect, Google Scholar, and Web of Science, were used to identify peer-reviewed research articles and reviews on the effects of airborne PM on skin. From among 540 articles identified, 75 articles were included for further consideration after manual screening of the articles. The articles that were excluded either did not contain data or were classified as editorials or conference abstracts. Finally, articles in languages other than English or German were also omitted.

The structure and function of human skin {#Sec2}
========================================

Mammalian skin is the largest organ in the human body and can be divided into two major layers, the epidermis and the dermis (Fig. [1](#Fig1){ref-type="fig"}). The dermis, the lower layer of the skin, is made of connective tissue and has a thickness of up to 3 mm. Fibroblasts are the primary cell type in this layer \[[@CR23], [@CR24]\]. These cells secrete collagen and elastin, which contribute to the generation of the extracellular matrix, providing the dermis with strain resistance and elasticity, respectively \[[@CR23], [@CR25], [@CR26]\]. Embedded within the dermis are structures such as nerve endings, sebaceous glands, hair follicles, and blood and lymphatic vessels \[[@CR24]\]. The vascular network provides nutrients and oxygen to the upper skin layers and their surrounding tissues. Additionally, the vascular network takes part in detoxification, regulation of temperature, and wound repair. Besides fibroblasts, there are various other cell types found in the dermis: endothelial cells, mast cells, macrophages, dendritic cells called Langerhans cells, T cells, and neutrophils. Numerous dermal immune cells provide an effective defense mechanism against the invasion of pathogens and exogenous substances \[[@CR27], [@CR28]\]. Fig. 1Schematic overview of the human skin. **(A)** The skin consists of the epidermis and the dermis. **(B)** The epidermal layer consists, from top to bottom, of the stratum corneum (SC), the stratum lucidum (SL), the stratum granulosum (SG), the stratum spinosum (SS), and the stratum basale (SB). Figure adopted with permission from van Smeden et al. \[[@CR22]\]

The layer above the dermis, the epidermis, is divided into four to five layers and contains mainly keratinocytes \[[@CR29]\]. The lower layer, the stratum basale (SB), is made of a single layer of undifferentiated keratinocytes. These cells are continually dividing and upon differentiation migrating up to the adjacent layer, the stratum spinosum (SS), where they start a maturation process, such as changing their shape from columnar to polygonal. The layer above the SS is the stratum granulosum (SG) that contains differentiated keratinocytes with a typical accumulation of cytoplasmic materials, e.g., keratohyalin granules. They also produce lamellar bodies (LBs) that secrete specific lipid compounds, which are essential for the formation of the uppermost layer of the skin, the stratum corneum (SC) \[[@CR30], [@CR31]\]. In thick skin, such as on the palms of the hands and soles of the feet, there is an additional thin layer named the stratum lucidum (SL), located between the SG and SC \[[@CR32]\]. The SC is a multiple layered tissue (e.g., 15--20 layers), which generally has a thickness of 10--20 μm \[[@CR33]\]. This layer consists of corneocytes that are terminally differentiated keratinocytes lacking both nucleus and cytoplasmic organelles \[[@CR33]--[@CR35]\], surrounded by a lipid matrix providing a permeability barrier. The described differentiation process is marked by the expression of early (e.g., cytokeratin 5 and 14) and late (e.g., cytokeratin 1 and 10) differentiation markers \[[@CR36]\]. Other cells found in the epidermis are melanocytes, dendritic cells (i.e., Langerhans cells), T cells (e.g., CD8+ cells), and Merkel cells \[[@CR29]\].

Epidemiology {#Sec3}
============

Exposure to airborne PM is associated with several skin diseases and disorders and has been extensively reviewed elsewhere \[[@CR20], [@CR21], [@CR37]--[@CR39]\].

In healthy skin, exposure to urban PM has been associated with accelerated extrinsic aging \[[@CR40]--[@CR42]\], its clinical symptoms being pigment spot formation, coarse wrinkle development, and elastosis \[[@CR43]\]. Further evidence from epidemiological, clinical studies, and in vitro studies, and aging mechanisms have been reviewed \[[@CR19], [@CR44]--[@CR46]\], all indicating the generation of free radicals, the activation of aryl hydrocarbon receptor signaling, the induction of inflammatory cascade, and finally the impairment of the skin barrier.

In Germany, a higher incidence of skin melanoma among women was reported for women living in rural areas compared to women living in non-rural areas \[[@CR47]\]. In another semi-individual cohort study, an increase in PM~10~ resulted in a 52% increase in the relative risk of non-melanoma skin cancer \[[@CR48]\]. The genotoxic potential of PM was further investigated in an in vitro study that showed (i) a positive dose-response relationship for PM-induced DNA reactivity, and (ii) the highest DNA reactivity for PM~2.5~ \[[@CR7]\].

The chronic relapsing inflammatory skin disease, atopic eczema (AE), is characterized by skin barrier defects, intense pruritus, and immunological dysregulation \[[@CR49]--[@CR51]\]. This disease is not only caused by genetic predisposition (i.e., filaggrin mutation) and a dysregulated immune system but also triggered by several environmental factors, including air pollution, as suggested by recent epidemiological reports \[[@CR20], [@CR52]\]. A meta-analysis on skin diseases due to PM exposure included 13 studies and showed correlations between PM~10~ and PM~2.5~-exposure and several skin diseases \[[@CR53]\]. It reported on a significant association between PM~2.5~-exposure of younger people (e.g., 2--30 years), which was not the case for PM~10~ exposure. However, with an odds ratio of 1.05 and the small quantity of observational, cohort studies, and individual studies, the statistical power of this meta-analysis is limited. Several new studies have been published that were not included in this meta-analysis \[[@CR54]--[@CR60]\]. More recently, Krämer and co-workers have reviewed this evidence by combining data from 57 environmental epidemiological studies in a systematic review \[[@CR61]\]. No sufficient evidence for a higher AE incidence upon large-scale exposure assessments of air pollution (PM~10~ and sulfur dioxide (SO~2~)) was reported. Contrary to the small-scale exposure assessments (PM~2.5~), where in most of the studies (23 out of 30), a significant association between AE and traffic-related emissions was determined. Additionally, in all of the panel studies, there was a strong correlation between the AE symptom severity and outdoor pollution. Interestingly, an association between maternal exposure to traffic-related pollution and AE incidence in the offspring was found. From the prospective birth cohort study, Cohort for Childhood Origin of Asthma and Allergic Diseases (COCOA) \[[@CR62]\], 468 one-year-olds were included with measurements of outdoor PM~10~ and PM~2.5~ and transepidermal water loss (TEWL), which is a measure for skin barrier dysfunction \[[@CR63]\]. The effects of prenatal PM exposures were studied during three trimesters on skin barrier dysfunction and AE \[[@CR64]\]. A positive correlation was found between prenatal PM exposure during the first trimester and the skin barrier dysfunction and AE in the offspring: early-onset AE and higher AE severity at age three. It is suggested that PM-induced oxidative stress could induce epigenetic changes in fundamental DNA repair genes in the placenta, which could affect fetal immune development. Pulmonary and intranasal exposure to PM~10~, PM~2.5~, and PM~0.1~ have been extensively studied for their ability to enhance Th2-related immune responses, their role as an immune adjuvant, and their effects on the development of atopic disease \[[@CR65]--[@CR67]\].

Dong and co-workers reviewed reports on PM exposure and skin inflammation in China and concluded that, indeed, PM emissions aggravate the symptoms of inflammatory skin diseases like AE \[[@CR68]\]. The aforementioned results have been supported by a recent review on the impact of different air pollutants on AE, which included a total of 21 in vitro studies, animal studies, clinical trials, and case studies \[[@CR69]\].

The exact mechanisms through which PM can aggravate AE symptoms are yet to be further investigated. Additionally, determining the synergistic effects of different air pollutants while taking solar radiation into account can be challenging and is often not addressed when studying the effect of a single pollutant on the skin \[[@CR70]\]. In a study from Japan, biopsies from 75 AE patients were investigated and a correlation was found between several oxidative stress markers in the SC and the severity of the disease \[[@CR71]\]. It is hypothesized that environmentally generated reactive oxygen species can induce oxidative damage to proteins in the SC. Eventually, this may lead to the disruption of the skin barrier and further exacerbation of AE. Additionally, the aryl hydrocarbon receptor may play a key role in PM-induced AE aggravation. It is suggested that PM and AE are linked by the activation of the aryl hydrocarbon receptor signaling pathway and transactivation of neurotrophic factor artemin, by ligand species that are adsorbed onto airborne PM \[[@CR72], [@CR73]\].

Thus far, the studies mostly investigated the link between AE and PM. However, it is hypothesized that patients with other inflammatory skin diseases with an impaired barrier function, such as the rare genetic skin disease Netherton syndrome \[[@CR74]\] and psoriasis \[[@CR75]\], are more prone to the effects of PM.

Simulating biological responses of the skin to airborne PM in vivo and in vitro {#Sec4}
===============================================================================

The effects of airborne PM on the skin and underlying mechanisms will be critically evaluated, i.e., by reviewing studies on exposure of in vitro human two-dimensional (2D) and three-dimensional (3D) models, and finally in vivo animal models. The studies used either standard reference materials or in-house diesel emission and urban particulate matter extracts as exposure constituents.

Airborne PM for experimental studies {#Sec5}
------------------------------------

As aforementioned, the composition of PM is complex and includes metals, organic compounds (e.g., organic carbon and materials of biological origin), inorganic carbonaceous material, sulfate, and nitrate, among others. To assess their health effects, different approaches have been applied, such as epidemiological studies, controlled exposure studies to a defined source, or collection of particles on filters which can then be used for further experiments. It is important to add that the thorough characterization of the particles, including particle size and chemical analysis of the adsorbed chemicals onto the particles to correlate observed effects, is challenging but highly relevant \[[@CR5]\].

The most common particles used in in vitro and in vivo studies to simulate the effects of airborne PM on the skin are Standard Reference Materials® available from the National Institute of Standards and Technology (NIST) \[[@CR76]\]. NIST offers three different diesel PM extracts: SRM® 1650b, SRM® 1975, and SRM® 2975. Both SRM® 1975 and SRM® 2975 contain diesel PM collected from a filtering system of a diesel-powered forklift engine. SRM® 1650b contains material that is obtained from the heat exchangers of a dilution tube connected to diesel engines. This standard reference material is considered representative of particulate emissions of heavy-duty diesel engines and can be categorized as PM~2.5~. Besides using certified standards, diesel particulate extracts from several different diesel engine emissions collected on filters have been extracted and tested on skin models. Additionally, NIST offers two airborne PM standards named SRM® 1649b and SRM® 1648a that have been collected in the Washington, DC area and the St. Louis, MO area, respectively, between 1976 and 1977. Other standards for fine atmospheric PM are SRM® 2787 (i.e., PM~10~) and SRM® 2786 (i.e., PM ≤ 4 μm) collected in Prague, the Czech Republic in 2005.

The Joint Research Centre (JRC) of the European Commission produces European Reference Materials (ERM) that are used to simulate airborne PM \[[@CR77]\]. JRC is accredited to ISO 17034, ensuring the appropriate quality of ERMs. They offer ERM-CZ100 and ERM-CZ120 fine urban dust particles that are processed in a way that resembles PM~10~-like urban dust without (e.g., ERM-CZ120) or with PAHs (ERM-CZ100). The National Institute for Environmental Studies (NIES) in Japan offers PM~10~-like urban dust certified reference material (CRM) no. 28 that have been collected from a central ventilating system in a building in Beijing, China \[[@CR78]\].

Several studies reported self-collection of airborne PM or PM from seasonal dust storms in Asia and West Africa, e.g., on building rooftops in Asia, using an in-house filtering system, yielding PM~2.5~. Others reported usage of concentrated ambient air particles (CAPs), which are airborne particles that are concentrated to PM~2.5~ for skin model exposure.

Skin models used to study airborne PM effects {#Sec6}
---------------------------------------------

### Animal models {#Sec7}

The main in vivo approaches to study skin responses to either drug permeation or toxicological outcome are either rodents (i.e., rats or mice) or pigs \[[@CR79]\]. Rodent skin differs significantly from human skin, due to considerably thinner skin layers and a higher hair follicle density, leading to higher substance permeation \[[@CR80]\]. On the contrary, porcine skin more closely resembles the structural properties of the human skin \[[@CR81]--[@CR84]\]; however the animals are more challenging to handle and have higher fat storage \[[@CR85]\].

Animal models are employed to compare PM effects on skin with a healthy and compromised barrier function. A disrupted barrier can be created by the conventional tape stripping method, which consists essentially of removing the SC of the animal skin model layer by layer \[[@CR86]--[@CR92]\]. Another approach is to use the NC/Nga mouse model that develops skin lesions that are comparable to human AE lesions \[[@CR93]--[@CR96]\].

Animal models have various disadvantages, besides their different physiological structures. Animal studies are highly time and cost-ineffective; they are restricted to many regulations and countless ethical concerns \[[@CR97]\]. To effectively comply with and implement the three R's (i.e., reduction, refinement, and replacement) \[[@CR98]\] for the laboratory use of animals, alternatives to animal testing like 2D and 3D in vitro human skin models should be considered to comply with the reduction and replacement concept \[[@CR99]\].

### In vitro human 2D models {#Sec8}

Human adult low calcium high temperature (HaCaT) cells are an immortalized keratinocyte cell line that is frequently used for 2D in vitro studies \[[@CR100]\]. However, a significant limitation of this cell line is their limited response to major T helper cell cytokines \[[@CR101]\]. It was shown that HaCaT cells respond differently to these pro-inflammatory cytokines compared to primary cells, resulting in different expression profiles of genes related to the development of the skin barrier \[[@CR102]\]. Therefore, a model using HaCaT cells that focuses on the pathophysiological response towards pro-inflammatory cytokines should necessitate careful interpretation. The cells that are considered more biologically relevant are primary cells, which are explanted directly from healthy donors. The primary skin cells that are most often studied concerning the effects of PM are normal human epidermal keratinocytes (NHEK) or normal human dermal fibroblasts (NHDF) monocultures. Human primary cells are either isolated from the neonatal foreskin or adult skin. In a study that investigated the proteome in primary keratinocytes with respect to gender and age, it was determined that there were only minor differences \[[@CR103]\]. Primary skin cells are cultured on specific substrates in an optimized cell culture medium and receive PM treatment directly in their culture medium, referred to as systemic treatment. Although the use of 2D models allows for easy, fast, and low-cost experiments, they lack a physiological skin barrier with a competent SC layer. Without this protective layer, the viable cells are in immediate contact with the tested substance. Therefore, systemic treatment of a 2D model consisting of living cells could result in an overestimation of the impact of the testing material and not resemble the real-life exposure situation. It was found that the keratinocytes cultured in 3D, even upon a systemic treatment, are more resistant to cytotoxic agents such as hydrogen peroxide compared to keratinocytes cultured in 2D \[[@CR104]\]. A recent study compared the effect of silver nanoparticles on oxidative stress and inflammation in 2D and 3D skin models \[[@CR105]\]. Cell viability was reduced, and the silver content was approximately 9-fold higher in 2D keratinocytes compared to a 3D model. Additionally, the oxidative stress and pro-inflammatory response were substantially stronger in a 2D model compared to a 3D model. For this reason, the use of a 3D skin model to better simulate the real-life topical exposure condition and assessment of the skin's barrier function upon the treatment is recommended.

### In vitro human 3D models {#Sec9}

The two main types of 3D models used to mimic human skin are human epidermal equivalents (HEE) and human skin equivalents (HSE) \[[@CR106], [@CR107]\].

Cultivation of HEE models starts with one cell type: either primary keratinocytes isolated from the human epidermis, or immortalized cell lines (e.g., N/TERT). These keratinocytes are grown in typical culture inserts on a supporting substrate, such as an inert membrane with a defined pore size or collagen matrix, using the air-liquid culture technique. This technique includes removing the cell culture medium from the upper side to expose the cells to air on one side, allowing the cells to 'feed' from the medium in the chamber underneath \[[@CR108]--[@CR110]\]. Upon stimulation with growth factors, insulin, ascorbic acid, and calcium, these keratinocytes can terminally differentiate into corneocytes, forming the upper layers of the epidermis over a time span of one to two weeks.

HSE models are comprised of both a dermal and an epidermal compartment consisting of fibroblasts embedded in a collagen matrix and keratinocytes, respectively. This two-compartmental model creates an interplay between the two skin layers, resulting in a better resemblance to human skin.

Although 3D skin models like the HSE and HEE are practical models that well-resemble the human skin, their barrier properties are less defined, due to a different SC lipid composition and a higher barrier permeability compared to that of native human skin \[[@CR80], [@CR111]--[@CR115]\]. In 3D models exposed to the air-liquid interface, PM can be applied either directly in the culture medium (systemic treatment) or on the topical side of the skin model either as aerosol or suspension (topical treatment). Topical treatment is considered more physiologically relevant compared to real-life exposures as opposed to systemic treatment.

Effects of PM in vivo and in vitro {#Sec10}
==================================

PM-induced skin barrier dysfunction and particle penetration {#Sec11}
------------------------------------------------------------

There are four different barrier compartments in the epidermis: physical, microbial, chemical, and immunological compartments \[[@CR106]\]. In this section, the effects of PM on the physical, microbial, and chemical barrier compartments will be reviewed.

### Microbial barrier {#Sec12}

The microbial barrier compartment consists of a diverse range of microorganisms, called the commensal skin microbiome that colonizes the skin. This includes colonization by millions of bacteria, fungi, and viruses, and the composition varies depending on the location of the skin \[[@CR116]\]. These commensals protect the skin by preventing infection by pathogenic microbes. Although the research field of the skin's microbiome has been given rise to many investigations over the last years \[[@CR116], [@CR117]\], studies on PM and the skin's microbiome are scarce. It was shown that the composition of children's skin microbiome was dependent on their age and living environment (e.g., rural versus urban), indicating a possible link between PM exposure and the skin microbiome composition \[[@CR118]\]. Nevertheless, the role of the microbial barrier in PM-induced damages remains yet to be unraveled.

### Physical barrier {#Sec13}

Reported findings on the effects of PM on the skin's barrier function in vivo and in vitro are summarized (Table [1](#Tab1){ref-type="table"}). Table 1Review of reported effects on the barrier function, such as proliferation, differentiation, and PM penetration in varying skin models upon exposure to PMModelPM typeDose and applicationExposure timeMain findingsRef.Ex vivo human skinSRM® 1649b2 mg/cm^2^, topical24 h- Pyknotic nuclei.- Decreased collagen-1 protein expression.\[[@CR119]\]PigSRM® 1648a and 1649b100 μg/m^2^, topical5 d- Decreased E-cadherin, cytokeratin, and filaggrin protein expression.\[[@CR120]\]Mice, BALB/c with disrupted barrierPM ≤1 μm from Seoul, Korea8 μg/cm^2^, topical6 h and 2 w repetitive exposures, 10 times total- Healthy barrier: PM remained in follicles.- Disrupted barrier: penetration of PM in SS.- Repeated exposure: dermal penetration of PM.\[[@CR121]\]Mice, BALB/cSRM® 1649b100 μg/m^2^, topical24 h repetitive exposures, 5 d total- Decreased filaggrin protein expression.\[[@CR122]\]Mice, HR-1SRM® 1650b100 μg/mL, topical7 d- PM internalization.\[[@CR123]\]SRM® 1650b100 μg/mL, topical7 d- Increased keratin 10 and PCNA protein expression.\[[@CR124]\]HSESRM® 2975200 μg/mL, systemic2 d repetitive exposures, 6 d total- Decreased keratin 16, keratin 17, and Ki67 protein expression.\[[@CR125]\]ERM-CZ120200 μg/mL, systemic48 h- Altered morphology of epidermis.\[[@CR126]\]HEEDiesel PM or vapor0.05% (v/v), systemic20 d- Decreased protein expression of cornifin A, suprabasin, and antileukoproteinase.\[[@CR127]\]CAPs, PM~2.5~0.5 and 2.0 μg/cm^2^, topical24 and 48 h- PM penetration in SC after 24 h.- PM penetration in deeper layers after 48 h.- No alterations in morphology.\[[@CR128]\]CRM no. 2825 mg, topical6 h- *Claudin 4* gene expression is upregulated.- No changes in mRNA expression of *filaggrin*, *loricrin*, *involucrin*, *transglutaminase 1*, *keratin 1*, *keratin 10*, *keratin 5*, and *keratin 14*.\[[@CR129]\]SRM® 1648a200 ppm, systemic96 h- Altered morphology.- Decreased PCNA and filaggrin protein expression.\[[@CR130]\]SRM® 1648a2.2, 8.9, and 17.9 μg/cm^2^, topical24 and 48 h- Decreased cytokeratin 10, involucrin, and loricrin protein expression.- Increased barrier permeability for 17.9 μg/cm^2^.- Increased protein expression of aquaporin 3.\[[@CR131]\]PM~2.5~ from Seoul, Korea50 μg/mL, topical24 h- Decreased keratin-10, claudin-1, desmocollin-1, and IFN-γ protein expression.- Increased S100A7 and S100A8 protein expression.\[[@CR132]\]PM~0.3--2.5~ from Benin, West-Africa30 μg/cm^2^, topical24 h- Decreased loricrin protein expression.\[[@CR133]\]PM~2.5~ from Xi'an, China50 μg/mL, systemic24 h repetitive exposures, 2, 4, or 6 d total- Increased cholesterol levels.- Reduced squalene levels.\[[@CR134]\]NHDFSRM®278730 μg/cm^2^, systemic24 h- PM internalization into autolysosomes.\[[@CR135]\]ERM-CZ100200 μg/mL, systemic24 h- Increased elastase and collagenase activity.- Increased procollagen protein expression.\[[@CR136]\]The pre-conditioned medium of HaCaT treated with CRM no. 28125 μg/mL, systemic30 m, 48 h post-incubation- Increased elastase and collagenase activity.\[[@CR137]\]NHEKPM~2.5~ from Xi'an, China50 μg/mL, systemic24 h- Top upregulated genes of transcriptomics analysis are *S100A8*, *S100A9*, *keratin 6B*, *keratin 19*, *serpin B3*, and mostly the genes are involved in cholesterol metabolism.\[[@CR134]\]Diesel PM or vapor0.05% (v/v), systemic20 d- Decreased envoplakin, suprabasin, filaggrin, involucrin, sciellin, caspase-14, cornifin-A protein, keratin-1, and keratin-10 protein expression.\[[@CR127]\]Diesel PM30 and 60 μg/mL, systemic24 h- PM internalization.\[[@CR138]\]Asian dust storm particles from Seoul, Korea25 μg/mL, systemic24 h- Increased *caspase 14* and *ITGA6* mRNA expression.\[[@CR139]\]PM ≤1 μm from Seoul, Korea40 μg/cm^2^, systemic24 h- PM internalization.\[[@CR121]\]PM~2.5~ from Seoul, Korea50 μg/mL, systemic2 or 4 d- Decreased number and length of cilia.- Increased SPRR3 protein expression.- Decreased *keratin 1*, *keratin 10*, and *IFT88* mRNA expression.\[[@CR140]\]SRM®27861 mg/mL, systemic6 h- RNA-Seq analysis: Upregulation of *keratin-associated protein 2--3*, *keratin 13*, *keratin 34*, and *claudin 4*. Downregulation of *growth differentiation factor 15*.\[[@CR141]\]PM~2.5~ from Seoul, Korea25 μg/mL, systemic24 h- Top upregulated genes from transcriptomics analysis are *SPRR* family members and other cornified envelope-related genes, *transglutaminase 3*, *involucrin*, *filaggrin*, *keratin 10*, *keratin 15*, *S100A7*, *S100A8*, *S100A9*, and *S10012*.\[[@CR132]\]HaCaTCRM no. 28125 μg/mL, systemic30 m, 24 h post-incubation- Increased elastase and collagenase activity.\[[@CR137]\]SRM® 1649b50 μg/cm^2^, systemic24 h- Decreased aquaporin-3 protein expression.\[[@CR142]\]SRM® 1649b50 μg/cm^2^, systemic24 h- Decreased filaggrin, repetin, involucrin, and loricrin protein expression after 24 h.\[[@CR143]\]PM~2.5~ from Shanghai, China10--100 μg/mL, systemic24 h- Increased involucrin, repetin, and filaggrin (highest dose) protein expression.- No changes in loricrin protein expression.\[[@CR144]\]SRM® 1649b25 and 50 μg/cm^2^, systemic4 and 24 h- Decreased filaggrin protein expression.\[[@CR122]\]SRM® 1650b50 μg/mL, systemic1, 4, 8, 12, and 24 h- PM internalization.\[[@CR123]\]SRM® 2975100 and 200 μg/mL, systemic24 h- No changes in loricrin protein expression.- Increased involucrin protein expression.- Decreased keratin 16, keratin 17, and Ki67 protein expression.- Decreased BrdU incorporation.\[[@CR125]\]CAPs, PM~2.5~5--25 μg/mL, systemic1, 3, 6, and 24 h- PM internalization.\[[@CR145]\]Abbreviations: w, week; d, day; h, hour; m, minute; HSE, human skin equivalent; HEE, human epidermal equivalent; NHEK, normal human epidermal keratinocyte; SRM, standard reference material; PM, particulate matter; CAP, concentrated ambient particles; SS, stratum spinosum; ppm, parts per million; CRM, certified reference material; BrdU, 5-bromo-2′-deoxyuridine

The physical barrier compartment of the skin can be seen as a so-called "outside-in" and "inside-out" barrier. The "outside-in" barrier consists of the SC, which protects against the penetration of pathogens, allergens, and other exogenous substances such as PM \[[@CR146], [@CR147]\]. Several distinct proteins in the epidermis are crucial to the terminal differentiation program and the barrier function of the skin, such as involucrin, loricrin, and profilaggrin \[[@CR148], [@CR149]\]. Keratin filaments in the SG keratinocytes interact with profilaggrin, leading to aggregation of these filaments. Additionally, the intracellular components are degraded, and the desmosomes are transformed into corneodesmosomes, linking the corneocytes together that results in a densely packed layer \[[@CR150]\]. The cornified envelope is formed around the plasma membrane and composed of structural proteins like involucrin and loricrin that are cross-linked by calcium-dependent transglutaminases \[[@CR147]\]. Another protein that is crucial to the cornified envelope structure is the members of the small proline-rich (SPRR) family. SPRR3 was shown to be upregulated in keratinocytes treated with PM~2.5~ \[[@CR132]\]. SPRR3 upregulation has been shown to decrease ciliogenesis in vitro \[[@CR140]\], which is responsible for suppressing skin pigmentation in melanocytes \[[@CR151]\].

The "inside-out" barrier, mainly provided by tight junctions, prevents excessive TEWL and, therefore, protects the skin against dehydration \[[@CR146], [@CR147], [@CR152]\]. It is likely that PM disrupts the barrier function of the skin, by modulating or even degrading the tight junctions. In other epithelial cells like lung cells or nasal cells, PM is shown to disrupt the barrier by modulating and even degrading tight junction proteins such as occludin, zona occludens-1 (ZO-1), and claudin-1 \[[@CR153], [@CR154]\]. Also, increased endothelial barrier permeability was shown to be PM-induced, due to ZO-1 degradation \[[@CR155]\].

In animal models, PM treatment mainly involved repetitive topical treatment for a longer time period (up to 2 weeks) of a relatively high dose (0.1--8 mg/m^2^), resulting in decreased expression of structural barrier protein like keratins and filaggrin \[[@CR120]--[@CR122]\]. In porcine skin, deterioration of the skin barrier by PM due to disrupted tight junctions led to increased skin permeability \[[@CR120]\]. In mice, penetration of PM was observed in both healthy skin and to a greater extent in the skin with a decreased barrier function (e.g., tape-stripped skin or skin of an AE mice model) \[[@CR121]\]. In 2D cultures, e.g., in keratinocytes and fibroblasts, cellular internalization of PM was observed after short-term exposures (i.e., 24 h) \[[@CR121], [@CR123], [@CR135], [@CR138], [@CR145]\]. It is important to note that engineered nanoparticles (e.g., single particles with a diameter less than 100 nm \[[@CR156]\]) have been reported to penetrate the first layers of the epidermis (i.e., SC and SG) and few reports on penetration into deeper layers of the viable epidermis or even dermal layers \[[@CR157], [@CR158]\]. However, the penetration of PM depending on size and agglomeration into the epidermis in healthy and diseased skin must be evaluated in future studies.

In 3D HSE models, a systemic treatment with PM (200 μg/mL) induced alterations in skin morphology and expression levels of structural proteins after a long time exposure (i.e., 48 h up to 6 days) \[[@CR125], [@CR126]\]. In 3D HEE models, PM usually in concentrations of up to 50 μg/mL was mainly applied topically and short-term exposures (i.e., 24 to 48 h) were performed \[[@CR128], [@CR130], [@CR132], [@CR133]\]. PM was shown to affect the physical epidermal barrier in 3D models, as indicated by altered expression of proteins important for epidermal differentiation, such as filaggrin, involucrin, loricrin, and keratins \[[@CR125], [@CR127], [@CR129], [@CR130], [@CR132], [@CR133]\]. Additionally, markers for proliferation, such as Ki67, 5-bromo-2′-deoxyuridine (BrdU) incorporation, and proliferating cell nuclear antigen (PCNA), were shown to be decreased upon PM exposure \[[@CR125], [@CR130]\]. Reduced expression of differentiation and proliferation markers was also shown in 2D models, i.e., HaCaT and NHEK cells \[[@CR122], [@CR125], [@CR127], [@CR140], [@CR141], [@CR143], [@CR144]\].

PM was also reported to affect the skin's cholesterol metabolism and increased cholesterol levels in 2D and 3D skin models \[[@CR134]\]. Cholesterol is one of the main lipid components of the matrix surrounding the corneocytes in the SC, thereby actively contributing to the permeability barrier on the epidermis. Altered cholesterol metabolism in the skin due to PM exposure could indicate an altered barrier function of the skin.

### Chemical barrier {#Sec14}

Keratinocytes are crucial to the production of antimicrobial peptides (AMPs), serving as the chemical barrier compartment, preventing microbial invasion at sites of damaged epithelium by directly terminating the pathogen. These molecules can destroy bacteria either by creating holes in their cellular walls or by sequestering iron, a crucial nutrient for bacterial growth \[[@CR159]\]. Examples of AMPs are cathelicidin (i.e., LL-37) \[[@CR160]\], defensins, and the S100 protein family \[[@CR161]\]. The expression of numerous genes that are encoding AMPs is differentially regulated by several pro-inflammatory cytokines \[[@CR162]\]. Increased AMP expression was observed in a 3D HEE and primary keratinocytes treated with PM \[[@CR132], [@CR134]\], indicating an alteration in the chemical epidermal barrier.

PM-induced oxidative stress {#Sec15}
---------------------------

One of the primary mechanisms of the adverse effects of PM is through the generation of ROS. ROS are a group of highly reactive chemical species that are derived from the oxygen metabolism characterized by an unpaired electron (e.g., hydroxyl radical and superoxide anion) \[[@CR163]\]. When the production of ROS overwhelms the skin's antioxidant defense, tissues incur an oxidative stress condition \[[@CR164]\]. ROS can damage lipids, proteins, and DNA, leading to oxidative injury via stress on several cellular organelles, resulting in tissue damage \[[@CR165]\]. Reports on PM-induced oxidative stress in the skin have been reviewed and summarized (Table [2](#Tab2){ref-type="table"}). In brief, PM can induce ROS generation via direct and indirect mechanisms, as further discussed in this section. Table 2Review of reported effects on oxidative stress in varying skin models upon exposure to PMModelPM typeDose and applicationExposure timeMain findingsRef.Ex vivo human skinSRM® 1649b2 mg/cm^2^, topical24 h- Lipid peroxidation.\[[@CR119]\]Mice, C-57Diesel PM4.5, 11.1 and 26.7 mg/cm^2^, topical80 h- Increased DNA adduct formation.\[[@CR166]\]Mice, FVB/NSRM® 1650b1 mg/time (PAH extracted), topical12 h- Increased *CYP1B1* mRNA expression.\[[@CR167]\]Mice, HR-1SRM® 1650b100 μg/mL, topical7 d- Increased protein carbonylation and lipid peroxidation.\[[@CR168]\]SRM® 1650b100 μg/mL, topical7 d- ER stress: upregulation protein expression of CHOP and GRP78.- Lipid peroxidation: increased expression of HNE protein.- Mitochondrial and ER swelling.- Increased protein carbonylation.- Apoptosis: increased protein expression of BAX, active caspase-3, and caspase-9, and DNA breakage.- Autophagy: increased protein expression of LC3B-II.\[[@CR123]\]SRM® 1650b100 μg/mL, topical7 d- Increased protein carbonylation.- Increased NOX4 protein expression.\[[@CR169]\]HSESRM® 2975200 μg/mL, systemic2 d repetitive exposure, 6 d total- Increased protein expression of cleaved caspase-3.\[[@CR125]\]HEECAPs, PM~2.5~0.5 and 2.0 μg/cm^2^, topical24 and 48 h- Increased isoprostanes protein level.- Increased HNE protein expression.- Increased CYP1A1 protein expression.- Increased DNA fragmentation.\[[@CR128]\]CAPs, PM~2.5~25 μg/mL, topical24 and 48 h- Increased protein carbonylation.\[[@CR170]\]PM~0.3--2.5~ from Benin, West-Africa30 μg/cm^2^, topical24 h- Increased HNE protein expression.- Increased *HMOX1*, *metallothionein 1G* and *1E, cyclin dependent kinase inhibitor 2A,* and *caspase 3* mRNA expression.- Decreased *BIRC5* mRNA expression.\[[@CR133]\]CRM no. 2825 mg, topical6 h- Upregulated mRNA expression of *CYP1A1*, *CYP1B1*, and *SOD2*.\[[@CR129]\]SRM® 19755 mg/mL, topical48 h- Increased level of carbonylated proteins\[[@CR171]\]SRM® 1648a2.2, 8.9, and 17.9 μg/cm^2^, topical24 and 48 h- Decreased AhR and increased NOTCH1 protein expression.\[[@CR131]\]NHDFSRM® 278730 μg/cm^2^, systemic24 h- Autophagy: accumulation of LC3-II.- Mitochondrial stress: deformed mitochondria.- Increased *CYP1A1* and *CYP1B1* mRNA expression.\[[@CR135]\]ERM-CZ10050--400 μg/mL, systemic3.3 h- Increased levels of intracellular ROS.\[[@CR136]\]The pre-conditioned medium of HaCaT treated with CRM no. 28125 μg/mL, systemic30 m, 48 h post-incubation- Increased levels of intracellular ROS.- Increased number of apoptotic bodies.\[[@CR137]\]SRM® 1649b50 μg/mL, systemic24 h- Increased intracellular ROS levels.- Activation of AhR (XRE activity).- Upregulation of *CYP1A1* mRNA expression.\[[@CR119]\]SRM® 1649b100--400 μg/mL, systemic24 h- Nuclear translocation of AhR.- Increased mRNA expression of *CYP1A1*.- Induced apoptosis.\[[@CR172]\]NHEKDiesel PM or vapour0.05% (v/v), systemic20 d- Increased Nrf2 protein expression.- Mitochondrial dysfunction: overexpression of proteins from mitochondrial complex I and IV.\[[@CR127]\]SRM® 19755 mg/mL, systemic1 and 24 h- Increased intracellular ROS levels.- Increased of *CYP1A1* mRNA expression.- Nuclear translocation of AhR.\[[@CR171]\]ERM-CZ1203, 10, 30 and 100 μg/mL, systemic24 and 48 h- Increased ROS levels after 24 h.- Increased *NOX1* and *NOX2* mRNA expression after 24 h.\[[@CR173]\]PM ≤1 μm from Seoul, Korea40 μg/cm^2^, systemic24 h- Increased ROS production.- Inhibition of ROS inhibited cytokine secretion.\[[@CR121]\]PM~2.5~ from Seoul, Korea25 μg/mL, systemic24 h- Top upregulated genes from transcriptomics analysis are *CYP1A1* and *CYP1B1.*\[[@CR132]\]PM~2.5~ from Xi'an, China50 μg/mL, systemic24 h- Top upregulated genes from transcriptomics analysis are *CYP1A1* and *SOD2*.\[[@CR134]\]Asian dust storm particles from Seoul, Korea25 μg/mL, systemic24 h- Increased *CYP1A1*, *CYP1A2*, and *CYP1B1* mRNA expression.\[[@CR139]\]Diesel PM30 and 60 μg/mL, systemic24 h- Increased ROS production.- Increased *HMOX1* mRNA and protein expression.- Increased *Nrf2* mRNA expression.\[[@CR138]\]SRM® 27861 mg/mL, systemic6 h- RNA-Seq analysis: Downregulation of ER stress apoptosis-related genes such as *ATF4* and *CHOP*. No activation of *BCL2*, *BAX*, *caspase 3*, and *caspase 8*.- Upregulation of *HMOX1*, *CYP1A1*, *CYP1B1*, and *NQO1*.\[[@CR141]\]SRM® 1650b and 297510 and 100 μg/mL, systemic1 and 24 h- Increased radical production.\[[@CR174]\]NHEK, HaCaT, and HEK001SRM® 1650b50 μg/mL, systemic72 h- Induced senescence: increased β-galactosidase activity.\[[@CR124]\]NHEK and HaCaTSRM® 1650b50 μg/mL, systemic0.5--48 h- Increased intracellular ROS levels.- Nuclear translocation of AhR (0.5 h).- Induced senescence: upregulation of P16^INK4A^ and increased number of SAHF/nuclei. Decreased colony-forming ability.- Senescence is AhR dependent.- Transcriptional regulation of P16^INK4A^ correlates with DNA demethylation: lower methylation of the P16^INK4A^ promoter region.\[[@CR124]\]NHDF and HaCaTSRM® 1650b50 μg/mL, systemic30 m and 24 h- Increased levels of lipid peroxidation and protein carbonylation after 24 h.- Increased levels of superoxide anion, hydroxyl radicals, and intracellular ROS (30 m).- Increased intracellular and mitochondrial calcium levels after 24 h.- Increased protein expression of CHOP, GRP78, active caspase-3, caspase-9, PARP, and BAX after 24 h.- Downregulated protein expression of Bcl-1 and Mcl-1 after 24 h.- Increased mitochondrial permeability after 24 h.- Reduced ATP levels after 24 h.- Increased DNA degradation and the number of apoptotic bodies after 24 h.\[[@CR175]\]HaCaTPM~2.5~ from Bangkok, Thailand100 μg/mL, systemic30 m- Increased intracellular ROS levels.\[[@CR176]\]PM~2.5~ from Taoyuan, China25, 50, 100 and 200 μg/mL, systemic24 h- Increased intracellular ROS levels.- Decreased SOD activity.- Increased lipid peroxidation: accumulation of MDA protein.- Induced formation of apoptotic bodies.- Induced protein expression of cytochrome c, active caspase-3, and caspase-9.- DNA damage.\[[@CR177]\]SRM® 1648a50--200 ppm, systemic24 and 48 h- Increased ROS production.\[[@CR130]\]SRM® 1648a SRM® 1649b50 μg/cm^2^, systemic24 h- Nuclear translocation of AhR.- Increased *CYP1A1* and *CYP1B1* mRNA expression.\[[@CR178]\]SRM® 1649b50 μg/cm^2^, systemic1 h- Increased levels of intracellular ROS.\[[@CR142]\]SRM® 1649b50 μg/cm^2^, systemic2 and 24 h- Increased cellular and mitochondrial ROS levels after 2 h.- Increased HMOX1 protein expression after 24 h.\[[@CR143]\]SRM® 1649b25 and 50 μg/cm^2^, systemic4 and 24 h- Increased ROS production.- Increased NOX activity.\[[@CR122]\]SRM® 1649b25--100 μg/cm^2^, systemic4 and 24 h- Increased NOX2 protein expression.- Increased ROS production.\[[@CR179]\]SRM® 1649b25 μg/mL, systemic2 and 24 h- Increased ROS production.\[[@CR180]\]SRM® 1649b50 μg/cm^2^, systemic1 and 4 h- Increased ROS production.- Increased NOX2 activity.\[[@CR181]\]SRM® 1649b25 and 50 μg/cm^2^, systemic4 and 24 h- Increased ROS production- Increased NOX activity.\[[@CR122]\]SRM® 1649b100--400 μg/mL, systemic24 h- Nuclear translocation of AhR.- Increased *CYP1A1* mRNA expression.- Induced apoptosis.\[[@CR172]\]SRM® 1650b50 μg/mL, systemic24 h- Increased cellular and mitochondrial ROS levels and mitochondrial stress.- Increased lipid peroxidation and protein carbonylation.- Increased cleaved caspase-3 and BAX and decreased Bcl-2 protein expression.- Induced DNA damage.- Increased number of apoptotic bodies.\[[@CR182]\]SRM® 1650b50 μg/mL, systemic1 and 24 h- Increased intracellular ROS and superoxide anion levels.- Increased levels of protein carbonylation and lipid peroxidation after 24 h.- Induced DNA damage and apoptotic body formation.- Increased mitochondrial permeability after 24 h.- Increased BAX, active caspase-3, and PARP and decreased Bcl-2 protein expression.\[[@CR183]\]SRM® 1650b50 μg/mL, systemic24 h- Increased intracellular ROS and calcium levels.- Increased levels of lipid peroxidation and protein carbonylation.- DNA damage.- Increased mitochondrial ROS, calcium, and permeability.- Apoptosis: increased protein expression of ATF6, GRP78, p-IRE1, BAX, and active caspase-3 and caspase-9. Decreased protein expression of Bcl2. Increased number of apoptotic bodies.- Autophagy: autophagic lysosomes. Increased protein expression of LC3B-II and beclin-1.\[[@CR168]\]SRM® 1650b50 μg/mL, systemic24 h- Increased intracellular ROS and superoxide levels.- Induced NOX activity.- Increased intracellular calcium levels and mitochondrial membrane permeability.- Induced lipid peroxidation and protein carbonylation.- DNA damage.- Increased number of apoptotic bodies.\[[@CR184]\]SRM® 1650b50 μg/mL, systemic1, 4, 8, 12, and 24 h- Increased intracellular ROS.- Increased levels of intracellular calcium.- ER stress: Increased protein expression of CHOP, GRP78, and p-PERK.- Increased mitochondrial permeability.- DNA damage.- Increased lipid peroxidation and protein carbonylation.- Apoptosis: Increased protein expression of BAX, DNA breakage, apoptotic body formation, and increased expression of active caspase-3 and caspase-9.- Autophagy: Increased protein expression of LC3B-II.\[[@CR123]\]SRM® 1650b50 μg/mL, systemic30 m, 1 h, and 24 h- Increased ROS production.- Increased levels of intracellular calcium.- Induced senescence.\[[@CR185]\]SRM® 1650b50 μg/mL, systemic24 h- Increased ROS production.- Increased lipid peroxidation.- Increased number of apoptotic bodies.\[[@CR186]\]SRM® 1650b and 297510 and 100 μg/mL, systemic1 and 24 h- No changes in radical production.\[[@CR174]\]SRM® 2975100 and 200 μg/mL, systemic24 h- Increased protein expression of cleaved caspase-3 and PARP.- Increased protein expression of BAX and p53.\[[@CR125]\]CRM no. 28125 μg/mL, systemic30 m, 24 h post-incubation- Increased levels of intracellular ROS.\[[@CR137]\]ERM-CZ120100 μg/mL, systemic30 m- Increased intracellular ROS production.\[[@CR126]\]ERM-CZ12025--100 μg/mL, systemic3 and 24 h- Increased CYP1A1 protein expression.- Decreased AhR protein expression.- Increased LC3-II and p62 protein expression.\[[@CR187]\]CAPs, PM~2.5~5--25 μg/mL, systemic1, 3, 6, and 24 h- Increased HNE protein adduct formation.- Increased nuclear translocation of Nrf2.- No changes in *GPX*, *GR*, and *NPQO1* mRNA expression.\[[@CR145]\]Abbreviations: h, hour; d, day; m, minute; HSE, human skin equivalent; HEE, human epidermal equivalent; NHEK, normal human epidermal keratinocyte; SRM, standard reference material; PM, particulate matter; CAP, concentrated ambient particles; ppm, parts per million; CRM, certified reference material; ROS, reactive oxygen species; PARP, poly (ADP-ribose) polymerase; Nrf2, nuclear factor erythroid 2-related factor 2; AhR, aryl hydrocarbon receptor; LC3-II, light-chain 3 II; BIRC5, baculoviral IAP repeat containing 5; NQO1, NAD(P) H quinone dehydrogenase 1; HMOX1, heme oxygenase 1; NOX, NADPH oxygenase; HNE, 4-hydroxy-2-nonenal; ER, endoplasmic reticulum; CYP1A1, cytochrome P450 family 1 subfamily A member 1

### PM triggers exogenous and endogenous ROS formation {#Sec16}

PM can trigger the formation of exogenous ROS levels through the formation of free radicals as a result of the high particle surface reactivity \[[@CR188], [@CR189]\]. Diesel PM and its organic extract were shown to both possess high reactivity by generating ROS via the catalyzation of oxygen reduction by various reductants \[[@CR190]\]. In addition, PAHs and quinones that are bound to the PM's surface have shown strong redox activity in vitro \[[@CR191]\]. Transition metals (e.g., copper and iron) present in PM can generate ROS through Fenton reactions \[[@CR192]\]. In keratinocytes, redox-active components such as copper and quinones were shown to induce oxidative stress by means of inducing the nuclear translocation of a redox-sensitive protein complex, causing mitochondrial stress and finally leading to apoptosis \[[@CR193]\]. The redox activity of PM is correlated to the size and the adsorbed species on the surface \[[@CR194]\]. Higher redox activity per PM mass was measured for ultrafine particles, compared to particles of a larger size. Moreover, a strong correlation was found between PM's redox activity and the mass fractions of species they carry (i.e., metals and PAHs).

Indirectly, PM or its adsorbed species (e.g., PAHs, quinones, metals) can increase endogenous ROS generation by inducing mitochondrial stress and increasing the activity of ROS producing enzymes. The mitochondria are commonly considered as the main source of ROS production in the cell. PM induces mitochondrial dysfunction, by inducing major structural damage \[[@CR123], [@CR135], [@CR195]\]. Typically, mitochondrial dysfunction is indicated by reduced ATP levels, as determined in PM~2.5~-treated keratinocytes and fibroblasts \[[@CR175]\]. This dysfunction leads to the generation of mitochondrial ROS, and to increased radical production and mitochondrial Ca^2+^ levels in vitro \[[@CR123], [@CR143], [@CR174], [@CR175], [@CR182]\]. As a result, the intracellular ROS levels were shown to increase substantially after 30 min of PM-treatment up to 24 h (e.g., 50 μg/mL) in 2D skin models \[[@CR119], [@CR121]--[@CR124], [@CR126], [@CR130], [@CR137], [@CR138], [@CR142], [@CR143], [@CR168], [@CR171], [@CR173], [@CR175], [@CR176], [@CR179]--[@CR186]\].

The endoplasmic reticulum (ER) is responsible for most of the intracellular Ca^2+,^ and, as a result, changes in the cellular Ca^2+^-balance activate ER stress \[[@CR196]\]. PM was shown to induce ER stress, as measured by increased levels of intracellular Ca^2+^ \[[@CR123], [@CR168], [@CR175], [@CR184]--[@CR186]\]. Additionally, the ER stress sensor proteins for unfolded or misfolded proteins, protein kinase-like ER kinase (PERK), inositol-requiring 1 alpha (IRE1α), and activating transcription factor 6 (ATF6) \[[@CR197]\], were activated in vitro \[[@CR123], [@CR175]\]. In vivo, mitochondrial and ER stress was observed after longer (e.g., 7 days) topical PM-exposure, as indicated by mitochondrial and ER swelling \[[@CR123]\].

Sensing exogenous chemical substances is paramount to stimulating an immune response as the first line of defense against these compounds. An important sensor of environmental chemicals is the aryl hydrocarbon receptor (AhR), a transcription factor that is highly expressed in all skin cells \[[@CR198]\]. Besides the xenobiotic metabolism and preserving the skin's homeostasis, the AhR plays a role in epidermal differentiation and barrier function of the skin \[[@CR199], [@CR200]\]. Common synthetic exogenous ligands are PAHs and halogenated aromatic hydrocarbons (HAHs) such as 2,3,7,8-tetrachlorodibenzodioxin (TCDD), dimethylbenz \[a\] anthracene (DMBA), methylcholanthrene or benzo\[a\]pyrene (BaP), coming from environmental air pollutants, such as PM \[[@CR201]\]. Upon binding to its ligand, the AhR translocates from the cytoplasm to the nucleus, where it forms a dimer with the AhR nuclear translocator (ARNT) \[[@CR202]\]. PM induces the nuclear translocation of AhR in vitro \[[@CR119], [@CR124], [@CR171], [@CR172], [@CR178]\]. The AhR/ARNT complex binds to conserved promoter regions containing the xenobiotic response element (XRE), promoting the transcription of several groups of target genes, such as from the phase I metabolism (e.g., cytochrome P450 family 1 subfamily A member 1, *CYP1A1*, *CYP1A2,* and *CYP1B1*), the phase II metabolism (e.g., UDP glucuronosyltransferase family 1 member A complex locus, *UGT1A* and glutathione S-transferase A1, *GSTA1*) and a gene for the aryl-hydrocarbon receptor repressor (*AhRR*) \[[@CR203]\]. CYP enzymes can metabolize PAHs, and the formed metabolites can induce cell damage either by the formation of DNA, protein adducts, or the generation of ROS \[[@CR195], [@CR204]--[@CR208]\]. Indeed, PM upregulates the CYP enzyme mRNA and protein expression in vitro and in vivo \[[@CR119], [@CR128], [@CR129], [@CR134], [@CR135], [@CR139], [@CR141], [@CR167], [@CR171], [@CR172], [@CR178], [@CR187]\].

Other ROS producing enzymes are the members of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) family \[[@CR209]\]. Once activated by PM \[[@CR122], [@CR169], [@CR173], [@CR179], [@CR181], [@CR184]\], these enzymes generate high levels of ROS.

### PM-induced oxidative stress results in lipid, protein, and DNA damage {#Sec17}

The skin is covered by a thin layer of sebum, that functions as a barrier against water evaporation (i.e., TEWL) \[[@CR210]\]. Sebum lipids, such as squalene, wax, cholesterol (esters), triglycerides, and free fatty acids, are a target for peroxidation by ROS. In addition to oxidation by exogenous ROS, endogenous ROS can target polyunsaturated fatty acids (PUFAs) from cell membranes, leading to the generation of reactive aldehyde byproducts like malondialdehyde (MDA) and 4-hydroxy-2-nonenal (HNE) \[[@CR211]\], commonly used as biomarkers for oxidative stress \[[@CR212], [@CR213]\]. Skin exposure to PM was found to induce lipid peroxidation, as well as elevated levels of reactive aldehyde byproducts \[[@CR119], [@CR123], [@CR128], [@CR133], [@CR145], [@CR168], [@CR175], [@CR177], [@CR182]--[@CR184]\]. These reactive aldehydes can, in turn, react with amino acid residues in proteins, resulting in the formation of carbonylated proteins \[[@CR214]\], which were also detected in the skin upon treatment with PM \[[@CR123], [@CR168]--[@CR171], [@CR175], [@CR182]--[@CR184]\]. The introduction of carbonyl groups (e.g., aldehydes and ketones) in proteins can also be caused by oxidative cleavage or the direct oxidation of amino acid residues \[[@CR214]\]. The formation of these highly stable carbonyl groups results in conformational changes and irreversible damage to the polypeptide chain. Subsequent unfolding and complete inactivation of the protein allows for protein crosslinking, leading to the formation of adducts \[[@CR215]\]. Also, DNA can be a target for ROS, and PM was shown to induce the formation of DNA adducts in mice skin \[[@CR166]\].

### Counteracting PM-induced oxidative stress {#Sec18}

The first line of defense against ROS is the cornified envelope, especially the SPRR family \[[@CR216]\]. It was shown that cysteine residues within the SPRR proteins are responsible for ROS quenching, most likely due to its location on the outer layer of the skin \[[@CR217]\]. Additionally, it was shown that common skin bacteria secrete specific proteins to counteract oxidative stress \[[@CR218]\].

Other defense mechanisms, to abrogate oxidative stress processes, are identified like the upregulation of antioxidant proteins and detoxifying enzymes that are activated by transcription factors via antioxidant response elements (ARE) \[[@CR165]\]. The expression and the subsequent nuclear translocation of one of these transcription factors, namely the nuclear factor erythroid 2-related factor 2 (Nrf2), is increased in vitro upon exposure to PM \[[@CR127], [@CR138], [@CR145]\]. In turn, Nrf2 target genes and their protein expression such as heme oxygenase 1 (HMOX1), NAD(P) H quinone dehydrogenase 1 (NQO1), glutathione S-transferases (GSTs) are upregulated \[[@CR127], [@CR133], [@CR138], [@CR141], [@CR143]\].

Activation of the AhR induces the nuclear translocation of Nrf2 by a mechanism that needs to be elucidated, but evidence suggests it involves protein kinases that induce transcription of detoxifying enzymes, leading to a decrease of ROS levels \[[@CR219]\].

### PM-induced apoptosis and autophagy {#Sec19}

Oxidative stress can lead to the activation of programmed cell death, i.e., apoptosis \[[@CR220]\]. Protein levels of CCAAT-enhancer-binding protein homologous protein (CHOP), a transcription factor that mediates ER-stress induced apoptosis \[[@CR221]\] and endoplasmic reticulum chaperone BiP (GRP78), a key element in normal ER function \[[@CR222]\], were determined to be upregulated by PM~2.5~ \[[@CR123], [@CR168], [@CR175]\]. Mitochondrial dysfunction leading to mitochondria-dependent apoptosis is characterized by increased permeability of the mitochondrial membrane \[[@CR223]\]. Mitochondria-dependent apoptosis (e.g., intrinsic pathway of apoptosis) is mediated by the release of cytochrome c and caspase activation (e.g., caspase-3 and caspase-9) \[[@CR223]\]. It was shown that PM induces mitochondrial-dependent apoptosis, indicated by an increased permeability of the mitochondrial membrane \[[@CR123], [@CR168], [@CR175], [@CR177], [@CR183], [@CR184]\], increased cellular cytochrome c \[[@CR177]\], and activation of caspase-3, caspase-9 and poly (ADP-ribose) polymerase (PARP) \[[@CR123], [@CR125], [@CR133], [@CR168], [@CR175], [@CR177], [@CR182]--[@CR184], [@CR186]\]. Furthermore, PM-induced apoptosis was observed by and upregulation of apoptosis regulator BAX, a downregulation of anti-apoptotic proteins Bcl-2 and Mcl-1 \[[@CR123], [@CR168], [@CR175], [@CR182]\], DNA fragmentation \[[@CR123], [@CR128], [@CR168], [@CR175], [@CR177], [@CR182]--[@CR184]\], and the formation of apoptotic bodies \[[@CR123], [@CR137], [@CR168], [@CR172], [@CR175], [@CR177], [@CR182]--[@CR184], [@CR186]\].

ER stress is also related to autophagy, and PM exposure was shown to promote autophagy in vitro*.* Proteins involved in the initiation of autophagosome formation, such as light-chain 3B II (LC3B-II) and Beclin 1, were shown to be upregulated \[[@CR123], [@CR135], [@CR168], [@CR175], [@CR224]\].

### PM-induced senescence {#Sec20}

Another mechanism that can be activated upon ROS-induced DNA damage is cellular senescence. Senescent cells are in irreversible arrest, thereby limiting proliferation, that is implicated in skin aging \[[@CR225]\]. It was shown that PM~2.5~ induces senescence in human keratinocytes (i.e., NHEK, HaCaT, and HEK001) \[[@CR124], [@CR172], [@CR185]\]. PM-induced senescence was shown to be dependent on ROS formation and subsequent AhR activation \[[@CR124]\]. The senescence inducer protein p16^INK4A^ was found to be upregulated upon PM~2.5~ treatment, and its transcription was shown to be epigenetically regulated through promoter methylation \[[@CR124]\]. In mice, topical PM exposure led to a hyperkeratotic epidermis. Epidermal hyperproliferation might result from the activation of the AhR, which is known to induce increased keratinocyte proliferation and differentiation \[[@CR200]\].

Activation of the inflammatory cascade {#Sec21}
--------------------------------------

The skin plays a major role in protecting the body from harmful environmental factors. The keratinocytes and immune cells contribute to the first and second lines of defense of the skin's immune system and are an indispensable part of the immunological barrier compartment. Additionally, the dermal fibroblasts play an important role in the sensing of pathogens, to protect the body further from harmful intrusive species. The reported findings on the effects of PM on the activation of the inflammatory cascade in skin models have been summarized (Table [3](#Tab3){ref-type="table"}). Table 3Review of reported effects on inflammatory cascade in varying skin models upon exposure to PMModelPM typeDose and applicationExposure timeMain findingsRef.Ex vivo human skinSRM® 1649b2 mg/cm^2^, topical24 h- Increased MMP-1 protein expression.\[[@CR119]\]Mice, BALB/cSRM® 1649b100 μg/m^2^, topical24 h repetitive exposure, 5 d total- Increased COX2 protein expression.\[[@CR122]\]SRM® 1649b100 μg/cm^2^, topical24 h repetitive exposure, 5 d total- Increased epidermal thickness.- Neutrophil infiltration.- Increased COX2 protein expression.\[[@CR179]\]Mice, BALB/c with disrupted barrierPM ≤1 μm from Seoul, Korea8 μg/cm^2^, topical6 h and 2 w repetitive exposures, 10 times in total- Increased epidermal thickness in both skin types.- Neutrophil infiltration.- Increased mRNA expression of IL-8 functional homologs (*KC*, *MIP2*, *LIX*).- Increased mRNA expression *MMP13*.\[[@CR121]\]Mice, NC/Nga, AE modelThe soluble phase of DEP.1 mg/time, topicalRepetitive exposure, every 1, 3, or 9 weeks in total- Increased AE lesion formation.- Increased total IgE levels.\[[@CR226]\]Mice, HR-1SRM® 1650b100 μg/mL, topical7 d- Increased epidermal thickness.\[[@CR124]\]SRM® 1650b100 μg/mL, topical7 d- Increased epidermal thickness.\[[@CR168]\]SRM® 1650b100 μg/mL, topical7 d- Increased IL-1β and IL-6 protein expression.- Increased TLR5 protein expression.- Increased MyD88 protein expression.- Increased phosphorylation of p65.\[[@CR169]\]HSESRM® 2975200 μg/mL, systemicEvery 2 d, 6 d total- Decreased IL-8, CXCL10, and ICAM1 protein secretion.\[[@CR125]\]HEECAPs, PM~2.5~0.5 and 2.0 μg/cm^2^, topical24 and 48 h- Nuclear translocation of p65.- Increased IL-1α protein secretion.- Increased COX2 protein expression.\[[@CR128]\]CRM no. 2825 mg, topical6 and 24 h- Upregulated mRNA expression of *IL1A*, *IL1B*, *IL6*, *CXCL8*, *CCL20*, *MMP1*, *MMP3*, *MMP9*, *MMP12*, and *ICAM1* after 6 h.- Downregulated expression of tissue inhibitors of MMPs (2--4) after 6 h.- Induced IL-8 and MMP-1 protein secretion after 24 h.\[[@CR129]\]PM~0.3--2.5~ from Benin, West-Africa15 and 30 μg/cm^2^, topical24 h- Increased IL-1α and IL-8 protein secretion.- Increased MMP-1 and MMP-3 protein expression.\[[@CR133]\]PM~2.5~ from Seoul, Korea50 μg/mL, topical24 h- Increased MMP-1 protein expression.\[[@CR132]\]SRM® 1648a2.2, 8.9, and 17.9 μg/cm^2^, topical24 and 48 h- Increased IL-1α protein secretion.\[[@CR131]\]NHDFSRM® 1649b100--400 μg/mL, systemic24 h- Phosphorylation of ERK and JNK.- Increased *MMP1* mRNA and protein expression.\[[@CR172]\]Diesel PM30 and 60 μg/mL, systemic24 h- Increased *MMP3* and *MMP9* mRNA expression.\[[@CR138]\]SRM® 1649b50 μg/mL, systemic24 h- Increased *MMP1* mRNA expression.\[[@CR119]\]SRM® 278730 μg/cm^2^, systemic24 h- Increased IL-6 and IL-8 protein secretion.- Increased MMP-1 and decreased procollagen and TGF-β protein secretion.- Increased *IL1B*, *IL6*, *CXCL8*, and *IL33* mRNA expression.- Increased *MMP1* and *MMP3* and decreased *TGFB*, *collagen type I alpha 1 chain*, *collagen type I alpha 2 chain*, and *elastin* mRNA expression.\[[@CR135]\]ERM-CZ100200 μg/mL, systemic24 h- Increased MMP-1, −2,-8, −9, −13 protein expression.- Nuclear translocation of p65.- Phosphorylation of ERK, JNK, and p38.\[[@CR136]\]The pre-conditioned medium of HaCaT treated with CRM no. 28125 μg/mL, systemic30 m, 48 h post-incubation- Increased PGE~2~, TNF-α, IL-1β, and IL-6 protein secretion.- Increased COX2 protein expression.- Nuclear translocation of p65.- Phosphorylation of p38, ERK, and JNK.- Increased MMP-1 and MMP-2 protein expression.\[[@CR137]\]Diesel PM30 and 60 μg/mL, systemic6 h- Increased *MMP2* and *MMP9* mRNA expression.\[[@CR227]\]NHDF and HaCaT co-cultureSRM® 1648a and SRM® 1649b50 μg/cm^2^, systemic24 h- Phosphorylation of p38.- Increased *IL1A*, *IL1B*, *IL6*, and *CXCL8* mRNA expression and protein secretion (HaCaT).- No changes in *TNF* mRNA expression and protein secretion (HaCaT).- Increased *MMP1* and *COX2* mRNA expression (NHDF).\[[@CR178]\]NHEKPM~2.5~ from Xi'an, China50 μg/mL, systemic24 h- Top upregulated genes from transcriptomics analysis are *CXCL1*, *IL1A*, and *IL1B*.\[[@CR134]\]Diesel PM30 and 60 μg/mL, systemic24 h- Increased *IL1A*, *IL6*, *CXCL8*, and *TNF* mRNA expression and protein secretion.\[[@CR138]\]ERM-CZ1203, 10, 30 and 100 μg/mL, systemic24 and 48 h- Increased *IL1B*, *IL6*, *CXCL8*, and *TNF* mRNA expression after 24 h.- Increased IL-1β, IL-6, IL-8, and TNF-α protein secretion after 48 h.- Increased *MMP1* mRNA expression and protein secretion after 24 h.\[[@CR173]\]SRM® 1650bUnknown24 h- Increased IL-1β and IL6 protein secretion.- Increased IL-6 protein expression.\[[@CR169]\]PM ≤1 μm from Seoul, Korea40 μg/cm^2^, systemic24 h- Increased *CXCL8* mRNA expression and protein secretion.- Increased *MMP1* mRNA expression and protein secretion.\[[@CR121]\]SRM® 27861 mg/mL, systemic6 h- RNA-Seq analysis: Upregulation of *IL1B*, *IL36G*, *CXCL3*, *CXCL8*, and *IL1R2*. Downregulation of *MMP3* and *MMP28*.\[[@CR141]\]SRM® 1649b50 μg/cm^2^, systemic24 h- Increased COX2 protein expression.\[[@CR181]\]SRM® 1649b100 μg/mL, systemic24 and 48 h- Increased IL-8 protein secretion.\[[@CR228]\]Diesel PM20 μg/mL, systemic48 h- Increased IL-1β and IL-8 protein secretion.\[[@CR229]\]Diesel PM30 and 60 μg/mL, systemic6 h- Increased *IL1A*, *IL6*, *CXCL8*, and *TNF* mRNA expression.\[[@CR227]\]Asian dust storm particles from Seoul, Korea25 μg/mL, systemic24 h- Increased *IL6*, *CXCL8*, and *CSF2* mRNA expression.- No changes in *IL1B*, *IFNG*, and *IL18* mRNA expression.\[[@CR139]\]PM~2.5~ from Seoul, Korea25 μg/mL, systemic24 h- Top upregulated genes from transcriptomics analysis are *IL1B*, *IL36G*, *IL1A*, *IL1R2*, *PTGS2*, *IRAK2*, *MMP1*, *MMP9*, and *MMP10*.- Downregulated gene is *CXCL14*.- Induced IL-1α protein secretion.- Phosphorylation of p65 and p38.\[[@CR132]\]HaCaTCRM no. 28125 μg/mL, systemic30 m, 48 h post-incubation- Increased PGE~2~, TNF-α, IL-1β, and IL6 protein secretion.- Increased COX2 protein expression.- Nuclear translocation of p65.- Phosphorylation of p38, ERK, and JNK.- Increased MMP-1 and MMP-2 protein expression.\[[@CR137]\]PM~2.5~ from Shanghai, China10--100 μg/mL, systemic24 h- No changes in CSF2 protein secretion.- Increased TSLP, TNF-α, IL-1α, and IL-8 protein secretion.\[[@CR144]\]SRM® 1648a50--200 ppm, systemic24 and 48 h- Increased *TRPV1* mRNA and protein expression (via p38/MAPK and NF-κB pathway).- Increased IL-1β, IL-8, and TNF-α protein secretion.\[[@CR130]\]SRM® 1648a and SRM® 1649b50 μg/cm^2^, systemic24 h- Induced phosphorylation of p-38.\[[@CR178]\]SRM® 1649b50 μg/cm^2^, systemic6 and 24 h- Increased phosphorylation of ERK, p38, JNK, and Akt after 6 h.- Increased COX2, ICAM1, cPLA~2~, and PGE~2~ protein expression after 24 h.- Increased MMP-9 protein expression after 24 h.\[[@CR143]\]SRM® 1649b50 μg/cm^2^, systemic2 and 6 h- Increased COX2 and MMP-9 protein expression.- Phosphorylation of ERK, JNK, and p38.\[[@CR142]\]SRM® 1649b25 and 50 μg/cm^2^, systemic4 and 24 h- Increased COX2 protein expression.- Increased PGE~2~ and IL-6 protein secretion.- No changes in IL-24, IL-1β, and TNF-α protein secretion.\[[@CR122]\]SRM® 1649b25--100 μg/cm^2^, systemic4 and 24 h- Increased COX2 protein (24 h) and mRNA (6 h) expression.- Increased PGE~2~ protein secretion after 24 h.- Nuclear translocation p65 after 4 h.- Phosphorylation of ERK, JNK, and p38 after 4 h.\[[@CR179]\]SRM® 1649b25 μg/mL, systemic2 and 24 h- Increased IL-6, IL-1β, and IL-1α protein secretion, and mRNA expression.- Phosphorylation of p38 and AP-1.\[[@CR180]\]SRM® 1649b50 μg/mL, systemicUK- Increased protein expression of COX2, PLA~2~, ICAM1, and MMP-9.- Phosphorylation of ERK, p38, and JNK.\[[@CR230]\]SRM® 1649b50 μg/cm^2^, systemic6 and 24 h- Increased COX2 protein (24 h) and mRNA (6 h) expression.- Increased PGE~2~ protein secretion.- Phosphorylation of p38, ERK, JNK, and p65.\[[@CR181]\]SRM® 1649b100--400 μg/mL, systemic24 h- Phosphorylation of ERK and JNK.- Increased *MMP1* mRNA and protein expression.\[[@CR172]\]SRM® 1650bUnknown1 h- Binding of PM to TLR5.\[[@CR169]\]SRM® 1650b50 μg/mL, systemic24 h- Induced phosphorylation of ERK, p38, and JNK.\[[@CR182]\]SRM® 1650bUnknown3 h- Increased IL-1β, IL-6, IL-8, IL-16, and TGF-β2 protein secretion.- Increased *IL6* mRNA expression.\[[@CR169]\]SRM® 1650bUnknown24--72 h- Increased IL-1β, IL-6, IL-8, IL-16, and TGF-β2 protein secretion.- Increased IL-6 protein expression (time-dependent increase).- Increased *IL6* mRNA expression.- Increased TLR5 protein and mRNA expression.- Increased MyD88 protein expression.- Nuclear translocation of p65.- NOX4-TLR5 interaction.\[[@CR169]\]SRM® 1650b50 μg/mL, systemic24 h- Phosphorylation of ERK, JNK, and p38.\[[@CR168]\]SRM® 1650b50 μg/mL, systemic30 m, 1 h, and 24 h- Increased MMP-1 protein activity, expression, and mRNA expression.- Increased MMP-2 and MMP-9 protein expression.- Activation of the MAPK pathway.- AP-1 binding to MMP-1 promotor.\[[@CR185]\]SRM® 2975100 and 200 μg/mL, systemic30 m and 24 h- Decreased IL-8 and CXCL10 protein secretion after 24 h.- Phosphorylation of p38, ERK, and JNK after 30 min.\[[@CR125]\]CAPs, PM~2.5~5--25 μg/mL, systemic1, 3, 6 and 24 h- Nuclear translocation of p65.- Increased IL-1α protein secretion.\[[@CR145]\]CRM no. 28125 μg/mL, systemic30 m, 24 h post-incubation- Nuclear translocation of p65.- Phosphorylation of p38, ERK, and JNK.- Increased PGE~2~, TNF-α, and IL-6 protein secretion.- Increased COX2 protein expression.\[[@CR137]\]CRM no. 28125 μg/mL, systemic30 m, 24 h post-incubation- Nuclear translocation of p65.- Phosphorylation of p38.- Increased COX2 protein expression.- Increased PGE~2~, IL-6, TNF-α, and IL-1β protein secretion.\[[@CR231]\]ERM-CZ100 and ERM-CZ120100 μg/mL, systemic24 h- Increased IL-1β, PGE~2~, and IL-6 protein secretion.- Increased COX2 protein expression.\[[@CR232]\]ERM-CZ120100--400 μg/mL, systemic24 and 48 h- Increased PGE~2~ protein secretion.\[[@CR126]\]HEK-001SRM® 1650bUnknown24 h- Increased IL-1β and IL-6 protein secretion.- Increased IL-6 protein expression.\[[@CR169]\]JB6 P+, mouse cell lineSRM® 197510--20 μg/mL, systemic12, 24, 36, and 48 h- Activation of NF-κB.- No activation of AP-1.- Activation of the Akt/PI3K pathway.- Phosphorylation of ERK, not of p38 and JNK.\[[@CR233]\]Abbreviations: h, hour; d, day; HSE, human skin equivalent; HEE, human epidermal equivalent; NHEK, normal human epidermal keratinocyte; SRM, standard reference material; PM, particulate matter; CAP, concentrated ambient particles; ppm, parts per million; CRM, certified reference material; CXCL10, C-X-C motif chemokine ligand 10; TLR, Toll-like receptor; IL, interleukin; MAPK, mitogen-activated protein kinase; TNF, tumor necrosis factor; MMP, matrix metalloprotease; NF-κB, nuclear factor kappa B; PGE~2~, prostaglandin E2; AP-1, adaptor protein 1

Activation of toll-like receptors {#Sec22}
---------------------------------

Keratinocytes in the viable epidermis (i.e., SG, SS, and SB) and dermal fibroblasts defend the human body by sensing pathogens and mediating an immune response by differentiating between harmful and harmless pathogens \[[@CR28]\]. They do so by the recognition of pathogen-associated molecular patterns (PAMPs), which are evolutionary conserved small molecular motifs within microbes, including lipopolysaccharide (LPS), peptidoglycan, flagellin and nucleic acids \[[@CR234]\]. These PAMPs trigger responses once they are recognized by pattern recognition receptors (PRR) \[[@CR235]\], such as members of the Toll-like receptor (TLR) family, located at the cell surface or in the cytoplasm \[[@CR236]\]. Keratinocytes constitutively express TLR1--6 and TLR9 \[[@CR237]\] whereas fibroblasts express all TLRs (i.e., 1--10) \[[@CR238]\]. Their activation is critical for provoking distinct immune responses in the skin \[[@CR236]\].

Activated TLRs can recruit and activate the adaptor molecule, myeloid differentiation primary response 88 (MyD88), to initiate signaling and activate the nuclear factor kappa B (NF-κB) pathway and members of the mitogen-activated protein kinase (MAPK) family \[[@CR237], [@CR239], [@CR240]\].

### PM-induced activation of NF-κB {#Sec23}

NF-κB represents a group of five inducible transcription factors that, once activated, mediate transcription of target genes by binding to a specific DNA element. Its target genes include an enormous amount of chemokines and cytokines among which tumor necrosis factor (*TNF*), interleukin 1 alpha (*IL1A*), interleukin 1 beta (*IL1B*) and chemokines such as C-X-C motif chemokine ligand 8 (*CXCL8*), have been shown to play a key role in the skin \[[@CR241]\]. In turn, the tumor necrosis factor (TNF), interleukin 1-alpha (IL-1α), and interleukin 1-beta (IL-1β) proteins can bind their respective receptors and transactivate NF-κB. Other target genes encode adhesion molecules like intercellular adhesion molecule 1 (*ICAM1*) and enzymes such as cyclooxygenase 2 (*COX2*) and inducible nitric oxide synthase (*iNOS*) \[[@CR241]\]. COX2 is an enzyme that is crucial for the formation of prostaglandin E~2~ (PGE~2~) derived from arachidonic acid from membrane phospholipids \[[@CR242]\].

PM~2.5~ was shown to be able to bind to TLR5 in keratinocytes \[[@CR169]\]. Additionally, it was determined that TLR5 interacts with MyD88 following PM exposure, both in vivo (mice) and in vitro \[[@CR169]\]. This, in turn, initiates the signaling cascade, and upon activation of NF-κB, the p65 subunit translocates to the nucleus, where it regulates the expression of its target genes that are involved in various processes of the inflammatory response \[[@CR241]\]. Indeed, PM induces the phosphorylation and nuclear translation of the p65 unit \[[@CR128], [@CR130], [@CR136], [@CR137], [@CR145], [@CR169], [@CR179], [@CR181], [@CR231], [@CR233]\]. The PM-induced activation of NF-κB leads to the increased transcription of its target genes and their protein expressions such as IL-1α, IL-1β, IL-6, IL-8, ICAM1, COX2 and TNF-α \[[@CR124], [@CR128], [@CR130], [@CR133], [@CR135], [@CR138], [@CR139], [@CR142], [@CR169], [@CR173], [@CR181], [@CR227], [@CR229], [@CR230], [@CR243]\]. PM-induced COX2 expression leads to induced production of PGE~2~ \[[@CR122], [@CR126], [@CR137], [@CR143], [@CR179], [@CR181], [@CR231], [@CR232]\].

Activation of NF- κB also leads to the transcription of the NLR family pyrin domain containing 3 (*NLRP3*) gene, which is a crucial priming signal for the activation of the inflammasome \[[@CR241]\]. The inflammasome is a large multi-protein, and its assembly leads to the activation of caspase-1, which in turn results in the cleavage of pro-IL-1β and pro-IL-18 that are stored in keratinocytes into biologically active IL-1β and IL-18, respectively \[[@CR244]--[@CR246]\]. A subsequent release enables adjacent epithelial cells to amplify this signal by stimulating the production of IL-1α, TNF-α, and IL-6. PM-induced activation of the inflammasome in the skin has not yet been studied; however in the pulmonary \[[@CR247]\] and cardiovascular \[[@CR248]\] systems, it was shown that PM activates the NLPR3 inflammasome in vivo (e.g., in mice).

Secretion of these chemokines and cytokines results in the regulation of an immune response by recruiting and activating different immune cell types into the skin, such as memory and effector T cells, and Langerhans cell precursors into the dermis and epidermis \[[@CR249]--[@CR251]\]. In vivo, the activation of the inflammatory cascade was observed through activation of NF-κB signaling with a resulting increased expression of pro-inflammatory cytokines upon topical exposure to PM \[[@CR121], [@CR122], [@CR169]\]. Additionally, an increase in epidermal thickness (i.e., an indicator for activation of the inflammatory cascade) and neutrophil infiltration was observed \[[@CR121], [@CR168], [@CR179], [@CR226]\].

In animal models with a disrupted skin barrier, topical PM application resulted in an upregulated expression of the functional homolog of IL-8, dermal cell infiltration, and increased epidermal thickness \[[@CR121]\]. This indicates that PM can aggravate symptoms from skin diseases with an already existing disrupted skin barrier like AE, supporting the epidemiological evidence that airborne PM can aggravate AE symptoms. Moreover, in AE mice models, topical application with the soluble phase of diesel PM (e.g., PAHs), resulted in increased lesion formation and increased immunoglobulin E (IgE) levels \[[@CR226]\].

### PM induces activation of MAPK proteins {#Sec24}

A different adaptor molecule, called TIR-domain-containing adapter-inducing interferon-β (TRIF), can be recruited by TLRs (e.g., TLR 3 and 4) and, in addition to MyD88, can initiate signaling of both NF-κB and MAPK \[[@CR240]\]. This activation of downstream signaling pathways results in the activation of MAPK members, such as extracellular-signal-regulated kinase (ERK), c-Jun-NH2-terminal kinase (JNK), p38, but also the transcription factor adaptor protein 1 (AP-1) \[[@CR252]\]. Exposure of fibroblasts and keratinocytes to PM was shown to induce the activation of the MAPK pathway by the phosphorylation of ERK, JNK, and p38 \[[@CR130], [@CR136], [@CR143], [@CR168], [@CR172], [@CR178], [@CR179], [@CR181], [@CR184]\].

A crosstalk between the previously described AhR and the MAPK pathway has been reported \[[@CR253]\]. The proto-oncogene tyrosine-protein kinase (c-Src), which is part of the AhR complex, is activated and released upon the binding of the AhR to its ligand \[[@CR253]\]. The soluble c-Src can in turn bind the epidermal growth factor receptor (EGFR) and activate the MAPK pathway \[[@CR253]\].

MAPK activation and the resulting activation of AP-1 leads to transcriptional regulation of matrix metalloproteinases (MMPs). The major sources of MMPs in the skin are keratinocytes and fibroblasts \[[@CR254]\], and they are responsible for remodeling of the dermis by the controlled degradation of the extracellular matrix (i.e., fragmentation of collagen fibrils) \[[@CR255]\]. As a result, higher MMP expression and activity leads to accelerated skin aging \[[@CR256]\]. Increased gene and protein levels of several matrix metalloproteinases (MMPs) were determined upon PM exposure in vivo and in vitro \[[@CR119], [@CR121], [@CR129], [@CR132], [@CR133], [@CR135], [@CR137], [@CR138], [@CR141]--[@CR143], [@CR172], [@CR173], [@CR178], [@CR185], [@CR227]\]*.*

Working model of the main affected pathways upon PM exposure to skin {#Sec25}
--------------------------------------------------------------------

It was shown in vitro and in vivo that PM-induced skin barrier dysfunction, oxidative stress, and inflammation are interconnected and exaggerate each other (see the working model in Fig. [2](#Fig2){ref-type="fig"}). Fig. 2The main affected pathways upon exposure of the skin to airborne PM. **(A)** PM disrupts the barrier of skin with an already existing barrier dysfunction to a greater extent. **(B)** The underlying mechanism of the effects of PM exposure on the skin. PM can disrupt the epidermal barrier by increasing the levels of antimicrobial peptides (AMP) and inhibiting the levels of proteins that are essential for cell differentiation and proliferation (i.e., FLG: Filaggrin, LOR: Loricrin, KERs: Keratins). PM induces both exogenous ROS (exROS) and endogenous ROS (ROS) formation by activation of the aryl hydrocarbon receptor (AhR), upon exposure to polycyclic hydrocarbons (PAHs), and increased activity of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzymes (NOX). A misbalance of ROS and antioxidant scavengers results in oxidative stress. ROS activates the nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) to propagate oxidative stress, by inducing the gene transcription of glutathione S-transferase (*GST*), heme oxygenase 1 (*HMOX1*), and NAD(P) H quinone dehydrogenase 1 (*NQO1*). ROS can cause damage to the skin by lipid peroxidation, protein carbonylation, and can cause irreversible cellular impairment through DNA damage. These damages, together with mitochondrial dysfunction, can lead to apoptosis. PM can activate the Toll-like receptor (TLR), leading to activation of the mitogen-activated protein kinase (MAPK) pathway and the nuclear factor kappa B (NF-κB) pathway. This, in turn, leads to an upregulation of gene expression of cytokines such as tumor necrosis factor (*TNF*), interleukin 1 alpha (*IL1A*), interleukin 1 beta (*IL1B*), as well as, chemokines such as C-X-C motif chemokine ligand 8 (*CXCL8*), adhesion molecules such as intercellular adhesion molecule 1 (*ICAM1*), enzymes such as cyclooxygenase 2 (*COX2*) and inducible nitric oxide synthase (*iNOS*), and matrix metalloproteases (*MMP*s). Fig. A is adapted with permission from van Smeden et al. and elements have been used for Fig. B \[[@CR247]\]

Protective solutions against PM-induced skin damage {#Sec26}
---------------------------------------------------

Understanding the underlying mechanisms of PM's adverse effects on human skin is crucial for the development of novel protective dermato-cosmetic technologies. To date, whereas only few technologies were developed to specifically target cutaneous damages induced by air pollutants in general, protection benefits against PM-induced skin damages were found for well-known cosmetic ingredients. Most of them are antioxidant based and aim to counteract the oxidative stress induced by PM and prevent the activation of the linked pro-inflammatory response. However, in most cases, the exact mechanism of action of these ingredients is yet to be elucidated.

Several active compounds were found to protect skin against PM-induced damage by inhibiting the expression of AhR. For example, N-acetylcysteine (NAC), was shown to suppress the expression of AhR and its nuclear translocation in human keratinocytes and attenuated the increase of intracellular ROS levels upon PM-treatment \[[@CR124]\]. In addition, topical NAC application in mice, showed to protect against ROS-AhR dependent PM-damage in the skin, by protecting from a PM-induced hyperkeratotic epidermis \[[@CR124]\]. In another study, the inhibition of the AhR with benzylidene dimethoxydimethylindanone in PM-treated keratinocytes and fibroblasts, resulted in decreased transcription of one of its target genes *CYP1A1* and in a decreased subsequent pro-inflammatory response by a decrease in MMP-1 protein expression \[[@CR172]\]. *Camellia japonica* flower extract was shown to have antioxidant properties in human fibroblasts by decreasing PM-induced intracellular ROS levels and subsequently inhibiting AhR activity and CYP1A1 transcription \[[@CR119]\]. In addition, this extract has shown to protect from PM-induced lipid peroxidation in an ex vivo human skin model \[[@CR119]\].

The potent antioxidant vitamin E was shown to rescue PM-induced damage in keratinocytes by partially restoring the expression of proteins that are important for proliferation, differentiation, and desmosomal integrity, among others \[[@CR127]\]. Resveratrol, another strong antioxidant, was shown to repress the PM-induced pro-inflammatory response in primary keratinocytes \[[@CR257]\].

Alginate extracted from *Sargassum horneri* was shown to have metal ion chelating properties by decreasing the concentration of PM metal traces (i.e., Pb, Ca, Sr, Ba, and Mg) in keratinocytes in a dose-dependent manner \[[@CR231]\]. This led to a decrease in intracellular ROS levels and downstream inactivation of the NF-κB and MAPK signaling pathways \[[@CR231]\].

Ethanol extract of *Cornus officinalis* fruit (EECF) \[[@CR183]\], a ROS scavenger, showed an antioxidant potential in HaCaT cells, by protecting against PM-induced DNA damage, lipid peroxidation, and protein carbonylation. It also prevented increases in cellular calcium levels and inhibited apoptosis \[[@CR183]\]. A pre-treatment with *Astragali Radix* or its main compound formononetin resulted in the protection against PM-induced decrease in keratinocyte proliferation and differentiation markers and blocked PM-induced apoptosis in a 2D and 3D skin model \[[@CR125]\]. Green tea extract has shown antioxidant and anti-inflammatory properties in keratinocytes \[[@CR134]\]. Additionally, it was shown to restore the PM-induced unbalance in cholesterol metabolism in a 3D HSE model \[[@CR134]\]. Moreover, the major polyphenolic antioxidant compound of green tea, epigallocatechin-3-gallate (EGCG), has shown ROS scavenging properties by decreasing PM-induced ROS levels in fibroblasts \[[@CR136]\]. In turn, this resulted in restoring elastase and collagenase activity and the expression level of several MMPs. Treatment with EGCG blocked the nuclear translocation of p65 as well as the phosphorylations of several MAPKs in a dose-dependent manner \[[@CR136]\]. A slight decrease of PM-induced ROS by EGCG in keratinocytes was shown to result in the balance restoration of TNF-α, IL-1β, IL-6, IL-8, and MMP-1 mRNA and protein levels \[[@CR173]\].

2′-Fucosyllactose (2FL) was tested in HaCaT and shown to have protective effects against PM~10~-induced pro-inflammatory response \[[@CR258]\]. Eckol, a phlorotannin extracted from seaweed, has shown antioxidant properties in keratinocytes \[[@CR182]\]. Treatment with eckol reduced PM-induced intracellular ROS levels, leading to maintenance of the mitochondrial function and protecting from MAPK activation and PM-induced apoptosis \[[@CR182]\]. Additionally, other algae extracts have shown to protect the skin from damage in vitro, such as *Ecklonia cava* extract and its compounds dieckol \[[@CR126]\], fucosterol \[[@CR137]\], diphlorethohydroxycarmalol \[[@CR168]\], afzelin \[[@CR180]\], and eupafolin \[[@CR179]\]. Ethyl 2,4-dicarboethoxy pantothenate, which is a derivative of pantothenic acid, was shown to reduce to PM-induced cellular damage \[[@CR171]\].

Niacinamide, a compound that is often used in various cosmetics, was shown to protect keratinocytes from PM-induced oxidative stress \[[@CR184]\]. Other reducing agents found to protect the skin against PM are 3,4-dicaffeoylquinic acid \[[@CR186]\], 7,3′,4′-trihydroxyisoflavone cyclodextrin inclusion complex \[[@CR142]\], isovitexin \[[@CR176]\], ginsenoside Rb1 \[[@CR175]\], chitosan \[[@CR259]\], and SIG-1273, a isoprenylcysteine small molecule \[[@CR228]\].

Nanoparticle technologies, such as 734THI nanoparticle powder \[[@CR230]\], eupafolin nanoparticles \[[@CR181]\], and nanomaterial fullerene derivate fullerenol \[[@CR143]\], were also considered as new players in the field of airborne PM protection.

Although most of the studies were carried out using an active ingredient only, protective effects against PM were demonstrated also from finished formulations. For example, a novel water-in-oil emulsion with a lecithin-modified bentonite, applied topically on a HEE 3D model, prevented skin damage from urban dust and cedar pollen, as indicated by the decrease in MMP-1 and IL-8 protein secretion \[[@CR129]\].

Future directions {#Sec27}
=================

2D skin models lack the barrier properties that 3D skin models have, and PM treatment can result in an overestimation of the real effect. Since the greater part of PM research on skin has been done using 2D models, it is interesting though challenging to translate the results into 3D models and even in vivo outcomes. In a recent study, the irritation potency of several compounds, has been compared in both 2D and 3D models \[[@CR260]\]. By screening 451 compounds in 2D models, they were able to select 46 compounds that showed cytotoxicity. From the 46 compounds, only seven compounds showed a cytotoxic potential in a HEE model and only one compound in a HSE model. This result underlines that 2D usually gives an overestimation of the assessed effect compared to 3D skin models. However, it can be used as a tool to gain preliminary knowledge on an expected response towards cytotoxicity, for example. The use of 3D skin models, such as HEE and HSE models, as an alternative to animal testing is recommended when testing the cutaneous effects of PM on skin. However, one must keep in mind that 3D skin models possess weaker barrier properties compared to the native skin. More advanced and relevant 3D skin models are developed that include immune cells, melanocytes, sebocytes, and endothelial cells, stimuli for lipid synthesis \[[@CR261]\], and cultivation conditions closer to the real-life situation \[[@CR262]\]; hence a complete immune system \[[@CR263]\], vascularization \[[@CR264]\], and barrier properties similar to human skin are the main elements that current models are lacking \[[@CR265]\]. Skin surface lipids (e.g., sebum) were not considered to date in 3D skin models utilized for PM-testing. As aforementioned, the skin surface lipids are prone to be oxidized by PAH-species adsorbed on PM, and their oxidation byproducts were shown to affect the skin. Therefore, it could be of high relevance to consider artificial sebum with a relevant lipid composition in 3D skin models to further understand the detrimental effects of PM on the skin \[[@CR266], [@CR267]\]. Moreover, testing of diseased skin models, such as AE 3D skin models, could offer more understanding of the underlying mechanisms of symptom aggravation upon exposure to PM \[[@CR265], [@CR268], [@CR269]\]. For the assessment of PM effects on skin aging, advanced skin models for skin aging research can be employed \[[@CR270]\].

When using 3D skin models, it is recommended to apply PM topically, that is a closer to real-life condition compared to systemic treatment. Additionally, the chemical interactions of PM with the skin and the PM properties upon interaction with the skin should be further investigated to perform exposure experiments that have a higher physiological relevance. It is important to study the correlation between PM source and composition on the effects that it has on the skin.

Most of the PM is coming from reference standards that can be either outdated (i.e., collected in 1976) or coming from a certain geographical region, leading to a wrong generalization of the current state of airborne PM. An example is testing of diesel particles: due to the continuously improving filtering systems of diesel cars, the emitted particles for the modern filter-equipped diesel cars are producing far less PM compared to gasoline cars \[[@CR271]\]. Although airborne PM is decreasing in the developed world, due to cars being equipped with improved filtering systems, the air quality in developing countries is a lot worse \[[@CR272]\], due to among other things, the lack of sufficient funds for these new filtering technologies. PM collected from different cities in a broader selection of the world, would give a better understanding of the real effects of PM on the skin.

PM is only one of the major hazardous elements of air pollution, and other elements, such as ozone and UV radiation, are important to investigate as well. Combined exposures of skin models, including several pollutants, would allow for a more relevant exposure scenario and give more insight into the interactions between the pollutants and the skin; hence synergistic damage of these pollutants is suggested \[[@CR273], [@CR274]\].

Taken together, these future directions could contribute to create recommendations for regulations to reduce airborne PM and for the dermato-cosmetic industry to design novel solutions for improved skin protection against air pollution.

Conclusions {#Sec28}
===========

The effects of airborne PM on skin have been intensively studied, but the majority is done in 2D skin models, especially in HaCaT cells and primary keratinocytes. Those cells are exposed to dispersed PM in cell culture media and thus reflect the real-life situation to a lesser extent, where the outer skin layer is consisting of the SC and exposed to air.

The results summarized do suggest not to limit our investigations to the assessment of oxidative stress and inflammation through ROS production and pro-inflammatory protein expression and secretion, respectively, but also to include implications in the complete mitochondrial respiratory chain, skin integrity, skin barrier function, epidermal differentiation and proliferation to the assessment.

Airborne PM has shown to affect several distinct cellular processes to a high degree, making it a very intriguing subject to study. Investigating these effects on a model that better resembles the complexity of human skin, a HSE or HEE model, or more advanced 3D skin models, will further reveal the involved cellular processes and effects on the health of human skin. By targeting these processes in both healthy and diseased skin, skin damage could be prevented and possibly cured by providing new solutions for the development of skincare products.
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